UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits and risks of nucleoside analog therapy for hepatitis B

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (S5), p.S112-S121

Dienstag, Jules L.

2009

Volltextzugriff (PDF)

American Gastroenterological Association Technical Review on the Management of Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2006-01, Vol.130 (1), p.231-264

2006

Volltextzugriff (PDF)

Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (21), p.11667-11673

2020

Volltextzugriff (PDF)

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009-01, Vol.136 (1), p.138-148

2009

Volltextzugriff (PDF)

American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2006-01, Vol.130 (1), p.225-230

2006

Volltextzugriff (PDF)

Introducing Raymond T. Chung, M.D., Our 2021 AASLD President

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.12-18

Dienstag, Jules L.

2021

Volltextzugriff (PDF)

Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.585-594

2010

Volltextzugriff (PDF)

Histological outcome during long-term lamivudine therapy

Gastroenterology (New York, N.Y. 1943), 2003-01, Vol.124 (1), p.105-117

2003

Volltextzugriff (PDF)

Evolution of the New Pathway Curriculum at Harvard Medical School: The New Integrated Curriculum

Perspectives in biology and medicine, 2011-12, Vol.54 (1), p.36-54

Dienstag, Jules L

2011

Volltextzugriff (PDF)

Kurt J. Isselbacher, M.D., Remembered (1925‐2019)

Hepatology (Baltimore, Md.), 2020-03, Vol.71 (3), p.1135-1139

Dienstag, Jules L.

2020

Volltextzugriff (PDF)

Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis

PloS one, 2012-02, Vol.7 (2), p.e27144-e27144

2012

Volltextzugriff (PDF)

The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort

Digestive diseases and sciences, 2011-02, Vol.56 (2), p.564-568

2011

Volltextzugriff (PDF)

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

The New England journal of medicine, 1999-10, Vol.341 (17), p.1256-1263

1999

Volltextzugriff (PDF)

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT‐C trial

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1675-1684

2006

Volltextzugriff (PDF)

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

Hepatology (Baltimore, Md.), 2002-07, Vol.36 (1), p.186-194

2002

Volltextzugriff (PDF)

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT‐C trial

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1738-1749

2009

Volltextzugriff (PDF)

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT

Clinical journal of the American Society of Nephrology, 2018-01, Vol.13 (1), p.16-25

2018

Volltextzugriff (PDF)

The role of liver biopsy in chronic hepatitis C: The role of liver biopsy in chronic hepatitis C

Hepatology (Baltimore, Md.), 2002-11, Vol.36 (5B), p.s152-s160

Dienstag, Jules L.

2002

Volltextzugriff (PDF)

Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians

Academic medicine, 2012-07, Vol.87 (7), p.845

2012

Volltextzugriff (PDF)

Hardened Liver Due to Fibrolamellar Hepatocellular Carcinoma

Clinical gastroenterology and hepatology, 2019-01, Vol.17 (1), p.A27-A27

2019

Volltextzugriff (PDF)

Liver Transplantation — A Vision Realized

The New England journal of medicine, 2012-10, Vol.367 (16), p.1483-1485

2012

Volltextzugriff (PDF)

Reply to: “Primed for the spotlight: Transplantation for alcohol-associated liver disease”

Journal of hepatology, 2018-07, Vol.69 (1), p.255-255

2018

Volltextzugriff (PDF)

Reply to: “Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach”

Journal of hepatology, 2018-06, Vol.68 (6), p.1323-1323

2018

Volltextzugriff (PDF)

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

The New England journal of medicine, 1995-12, Vol.333 (25), p.1657-1661

1995

Volltextzugriff (PDF)

Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease

Clinical gastroenterology and hepatology, 2019-11, Vol.17 (12), p.2592-2599

2019

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(205)

Publikationsform

Sprache

Englisch
(285)
Japanisch
(43)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(195)
Science & Technology
(193)
Life Sciences & Biomedicine
(188)
Male
(100)
Female
(95)
Gastroenterology & Hepatology
(87)
Biological And Medical Sciences
(76)
Middle Aged
(76)
Medical Sciences
(74)
Adult
(73)
Infectious Diseases
(62)
Viral Hepatitis
(57)
Human Viral Diseases
(54)
Viral Diseases
(54)
General & Internal Medicine
(50)
Medicine, General & Internal
(50)
Antiviral Agents - Therapeutic Use
(40)
Hepatitis
(35)
Hepatitis C, Chronic - Drug Therapy
(35)
Recombinant Proteins
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Benefits and risks of nucleoside analog therapy for hepatitis B

American Gastroenterological Association Technical Review on the Management of Hepatitis C

Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C

Introducing Raymond T. Chung, M.D., Our 2021 AASLD President

Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial

Histological outcome during long-term lamivudine therapy

Evolution of the New Pathway Curriculum at Harvard Medical School: The New Integrated Curriculum

Kurt J. Isselbacher, M.D., Remembered (1925‐2019)

Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis

The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT‐C trial

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT‐C trial

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT

The role of liver biopsy in chronic hepatitis C: The role of liver biopsy in chronic hepatitis C

Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians

Hardened Liver Due to Fibrolamellar Hepatocellular Carcinoma

Liver Transplantation — A Vision Realized

Reply to: “Primed for the spotlight: Transplantation for alcohol-associated liver disease”

Reply to: “Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach”

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease

Suchergebnisse filtern